{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "from tqdm import tqdm\n",
    "from collections import defaultdict\n",
    "from itertools import combinations\n",
    "import requests\n",
    "import re"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## How to obtain information about the pathways of a given gene\n",
    "First, the list of genes is loaded, as well as the index for the counts (the index of the counts is to filter out genes that I identified in papers but are not in our database)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "genes = list(pd.read_csv('genes.csv')['name'])\n",
    "index = pd.read_csv('pe-rna-counts.csv', index_col=0).index"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Then a dictionary is created to convert the common name to the ensembl code, and the genes that we don't have in our database are filtered out to 71 genes\n",
    "\n",
    "Then duplicates are removed to yeild 66 individual genes"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "should be 78 78\n",
      "should be 73 73\n"
     ]
    }
   ],
   "source": [
    "to_ensembl = pd.read_csv('genes.csv').set_index(\"name\")[\"code\"].to_dict()\n",
    "genes = [g for g in genes if to_ensembl[g] in index]\n",
    "print(\"should be 78\", len(genes)) \n",
    "genes = list(set(genes))\n",
    "print(\"should be 73\", len(genes)) "
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "So now we have our list of genes that we need to find pathways of\n",
    "\n",
    "Then, a dictionary is created with keys of genes and values of pathways, using the PathwayCommons API. This takes around 17 seconds because APIs can take time "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "  0%|          | 0/73 [00:00<?, ?it/s]"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|██████████| 73/73 [00:22<00:00,  3.22it/s]\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "{'SH3BP5': ['BCR signaling pathway'],\n",
       " 'ARNT2': [],\n",
       " 'FN1': ['Extracellular matrix organization',\n",
       "  'Beta3 integrin cell surface interactions',\n",
       "  'Angiopoietin receptor Tie2-mediated signaling',\n",
       "  'Alpha4 beta1 integrin signaling events',\n",
       "  'Syndecan-4-mediated signaling events',\n",
       "  'Integrin signaling pathway ( Integrin signaling pathway )',\n",
       "  'VEGFR3 signaling in lymphatic endothelium',\n",
       "  'Integrins in angiogenesis',\n",
       "  'Beta5 beta6 beta7 and beta8 integrin cell surface interactions',\n",
       "  'Integrin signalling pathway',\n",
       "  'Beta1 integrin cell surface interactions',\n",
       "  'Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling',\n",
       "  'Syndecan-2-mediated signaling events',\n",
       "  'Alpha9 beta1 integrin signaling events',\n",
       "  'Hemostasis'],\n",
       " 'RPL34': ['Protein Synthesis: Glutamic Acid',\n",
       "  'Protein Synthesis: Isoleucine',\n",
       "  'Protein Synthesis: Serine',\n",
       "  'Protein Synthesis: Threonine',\n",
       "  'Protein Synthesis: Valine',\n",
       "  'Protein Synthesis: Alanine',\n",
       "  'Protein Synthesis: Tryptophan',\n",
       "  'Protein Synthesis: Tyrosine',\n",
       "  'Protein Synthesis: Aspartic Acid',\n",
       "  'Protein Synthesis: Methionine',\n",
       "  'Protein Synthesis: Phenylalanine',\n",
       "  'Protein Synthesis: Leucine',\n",
       "  'Protein Synthesis: Asparagine',\n",
       "  'Protein Synthesis: Glutamine',\n",
       "  'Protein Synthesis: Glycine',\n",
       "  'Protein Synthesis: Cysteine',\n",
       "  'Protein Synthesis: Arginine',\n",
       "  'Protein Synthesis: Lysine',\n",
       "  'Protein Synthesis: Histidine',\n",
       "  'Protein Synthesis: Proline'],\n",
       " 'VSIG4': [],\n",
       " 'EPHX1': ['Metabolism of xenobiotics by cytochrome P450',\n",
       "  'Phenytoin (Antiarrhythmic) Action Pathway',\n",
       "  'Carbamazepine Metabolism Pathway'],\n",
       " 'PLEKHG1': [],\n",
       " 'RPL17': ['Protein Synthesis: Glutamic Acid',\n",
       "  'Protein Synthesis: Isoleucine',\n",
       "  'Protein Synthesis: Serine',\n",
       "  'Protein Synthesis: Threonine',\n",
       "  'Protein Synthesis: Valine',\n",
       "  'Protein Synthesis: Alanine',\n",
       "  'Protein Synthesis: Tryptophan',\n",
       "  'Protein Synthesis: Tyrosine',\n",
       "  'Protein Synthesis: Aspartic Acid',\n",
       "  'Protein Synthesis: Methionine',\n",
       "  'Protein Synthesis: Phenylalanine',\n",
       "  'Protein Synthesis: Leucine',\n",
       "  'Protein Synthesis: Asparagine',\n",
       "  'Protein Synthesis: Glutamine',\n",
       "  'Protein Synthesis: Glycine',\n",
       "  'Protein Synthesis: Cysteine',\n",
       "  'Protein Synthesis: Arginine',\n",
       "  'Protein Synthesis: Lysine',\n",
       "  'Protein Synthesis: Histidine',\n",
       "  'Protein Synthesis: Proline'],\n",
       " 'DIO2': [],\n",
       " 'NPM1': ['Aurora B signaling',\n",
       "  'Validated targets of C-MYC transcriptional activation',\n",
       "  'HIF-1-alpha transcription factor network'],\n",
       " 'FSTL3': [],\n",
       " 'GSTP1': ['4-hydroxy-2-nonenal detoxification',\n",
       "  'glutathione-mediated detoxification I',\n",
       "  'Metabolism of xenobiotics by cytochrome P450',\n",
       "  'Drug metabolism - cytochrome P450',\n",
       "  'Acetaminophen Metabolism Pathway'],\n",
       " 'RPL23': ['p53 pathway',\n",
       "  'Protein Synthesis: Glutamic Acid',\n",
       "  'Protein Synthesis: Isoleucine',\n",
       "  'Protein Synthesis: Serine',\n",
       "  'Protein Synthesis: Threonine',\n",
       "  'Protein Synthesis: Valine',\n",
       "  'Protein Synthesis: Alanine',\n",
       "  'Protein Synthesis: Tryptophan',\n",
       "  'Protein Synthesis: Tyrosine',\n",
       "  'Protein Synthesis: Aspartic Acid',\n",
       "  'Protein Synthesis: Methionine',\n",
       "  'Protein Synthesis: Phenylalanine',\n",
       "  'Protein Synthesis: Leucine',\n",
       "  'Protein Synthesis: Asparagine',\n",
       "  'Protein Synthesis: Glutamine',\n",
       "  'Protein Synthesis: Glycine',\n",
       "  'Protein Synthesis: Cysteine',\n",
       "  'Protein Synthesis: Arginine',\n",
       "  'Protein Synthesis: Lysine',\n",
       "  'Protein Synthesis: Histidine',\n",
       "  'Protein Synthesis: Proline'],\n",
       " 'PGF': ['VEGFR1 specific signals', 'VEGF and VEGFR signaling network'],\n",
       " 'HK2': ['HIF-1-alpha transcription factor network',\n",
       "  'Metabolic pathways',\n",
       "  'Triosephosphate Isomerase Deficiency',\n",
       "  'Fanconi-Bickel Syndrome',\n",
       "  'Glycogenosis, Type III. Cori Disease, Debrancher Glycogenosis',\n",
       "  'Glycogenosis, Type IA. Von Gierke Disease',\n",
       "  'Mucopolysaccharidosis VII. Sly Syndrome',\n",
       "  'Glycogenosis, Type IB',\n",
       "  'Glycogenosis, Type VII. Tarui Disease',\n",
       "  'Phosphoenolpyruvate Carboxykinase Deficiency 1 (PEPCK1)',\n",
       "  'Glycogenosis, Type VI. Hers Disease',\n",
       "  'Sucrase-Isomaltase Deficiency',\n",
       "  'Glycogen Synthetase Deficiency',\n",
       "  'Glycogenosis, Type IC',\n",
       "  'Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease',\n",
       "  'Gluconeogenesis',\n",
       "  'Glycolysis',\n",
       "  'Fructose galactose metabolism',\n",
       "  'Glycolysis and Gluconeogenesis ( Glycolysis and Gluconeogenesis )',\n",
       "  'Glycolysis',\n",
       "  'Pentose phosphate pathway',\n",
       "  'Aminosugars metabolism ( Aminosugars metabolism )',\n",
       "  'Fructose and Mannose metabolism ( Fructose and Mannose metabolism )',\n",
       "  'Starch and Sucrose Metabolism',\n",
       "  'Warburg Effect',\n",
       "  'Fructose-1,6-diphosphatase Deficiency',\n",
       "  'Glycogenosis, Type IV. Amylopectinosis, Anderson Disease'],\n",
       " 'NDRG1': ['Validated targets of C-MYC transcriptional repression',\n",
       "  'HIF-1-alpha transcription factor network',\n",
       "  'Direct p53 effectors'],\n",
       " 'SERPINB9': [],\n",
       " 'SASH1': [],\n",
       " 'RPS29': ['Protein Synthesis: Glutamic Acid',\n",
       "  'Protein Synthesis: Isoleucine',\n",
       "  'Protein Synthesis: Serine',\n",
       "  'Protein Synthesis: Threonine',\n",
       "  'Protein Synthesis: Valine',\n",
       "  'Protein Synthesis: Alanine',\n",
       "  'Protein Synthesis: Tryptophan',\n",
       "  'Protein Synthesis: Tyrosine',\n",
       "  'Protein Synthesis: Aspartic Acid',\n",
       "  'Protein Synthesis: Methionine',\n",
       "  'Protein Synthesis: Phenylalanine',\n",
       "  'Protein Synthesis: Leucine',\n",
       "  'Protein Synthesis: Asparagine',\n",
       "  'Protein Synthesis: Glutamine',\n",
       "  'Protein Synthesis: Glycine',\n",
       "  'Protein Synthesis: Cysteine',\n",
       "  'Protein Synthesis: Arginine',\n",
       "  'Protein Synthesis: Lysine',\n",
       "  'Protein Synthesis: Histidine',\n",
       "  'Protein Synthesis: Proline'],\n",
       " 'SIGLEC6': [],\n",
       " 'TUBB6': ['Cytoskeletal regulation by Rho GTPase', 'Huntington disease'],\n",
       " 'EEF1A1': ['EGFR1', 'Autophagy', 'Cellular responses to external stimuli'],\n",
       " 'IL18BP': [],\n",
       " 'ERAP1': [],\n",
       " 'FAU': ['Protein Synthesis: Glutamic Acid',\n",
       "  'Protein Synthesis: Isoleucine',\n",
       "  'Protein Synthesis: Serine',\n",
       "  'Protein Synthesis: Threonine',\n",
       "  'Protein Synthesis: Valine',\n",
       "  'Protein Synthesis: Alanine',\n",
       "  'Protein Synthesis: Tryptophan',\n",
       "  'Protein Synthesis: Tyrosine',\n",
       "  'Protein Synthesis: Aspartic Acid',\n",
       "  'Protein Synthesis: Methionine',\n",
       "  'Protein Synthesis: Phenylalanine',\n",
       "  'Protein Synthesis: Leucine',\n",
       "  'Protein Synthesis: Asparagine',\n",
       "  'Protein Synthesis: Glutamine',\n",
       "  'Protein Synthesis: Glycine',\n",
       "  'Protein Synthesis: Cysteine',\n",
       "  'Protein Synthesis: Arginine',\n",
       "  'Protein Synthesis: Lysine',\n",
       "  'Protein Synthesis: Histidine',\n",
       "  'Protein Synthesis: Proline'],\n",
       " 'ZNF175': [],\n",
       " 'C1QB': ['Classical Complement Pathway', 'Complement Pathway'],\n",
       " 'RPL31': ['Protein Synthesis: Glutamic Acid',\n",
       "  'Protein Synthesis: Isoleucine',\n",
       "  'Protein Synthesis: Serine',\n",
       "  'Protein Synthesis: Threonine',\n",
       "  'Protein Synthesis: Valine',\n",
       "  'Protein Synthesis: Alanine',\n",
       "  'Protein Synthesis: Tryptophan',\n",
       "  'Protein Synthesis: Tyrosine',\n",
       "  'Protein Synthesis: Aspartic Acid',\n",
       "  'Protein Synthesis: Methionine',\n",
       "  'Protein Synthesis: Phenylalanine',\n",
       "  'Protein Synthesis: Leucine',\n",
       "  'Protein Synthesis: Asparagine',\n",
       "  'Protein Synthesis: Glutamine',\n",
       "  'Protein Synthesis: Glycine',\n",
       "  'Protein Synthesis: Cysteine',\n",
       "  'Protein Synthesis: Arginine',\n",
       "  'Protein Synthesis: Lysine',\n",
       "  'Protein Synthesis: Histidine',\n",
       "  'Protein Synthesis: Proline'],\n",
       " 'ERAP2': [],\n",
       " 'BHLHE40': ['Fanconi anemia pathway',\n",
       "  'Circadian rhythm pathway',\n",
       "  'HIF-1-alpha transcription factor network',\n",
       "  'HIF-2-alpha transcription factor network',\n",
       "  'Circadian Clock'],\n",
       " 'TET3': ['Gene expression (Transcription)'],\n",
       " 'VEGFA': ['VEGF and VEGFR signaling network',\n",
       "  'Signaling events mediated by VEGFR1 and VEGFR2',\n",
       "  'VEGFR1 specific signals',\n",
       "  'Integrins in angiogenesis',\n",
       "  'S1P1 pathway',\n",
       "  'Alpha9 beta1 integrin signaling events',\n",
       "  'Beta3 integrin cell surface interactions',\n",
       "  'Signaling events mediated by TCPTP',\n",
       "  'S1P3 pathway',\n",
       "  'Plexin-D1 Signaling',\n",
       "  'HIF-2-alpha transcription factor network',\n",
       "  'HIF-1-alpha transcription factor network',\n",
       "  'SHP2 signaling',\n",
       "  'Glypican 1 network',\n",
       "  'Heterotrimeric GPCR signaling pathway (through G alpha i and pertussis toxin) ( GPCR signaling (pertussis toxin) )',\n",
       "  'Heterotrimeric GPCR signaling pathway (through_G alpha s_ACs_PKA_BRaf_and_ERKcascade)(canonical) ( GPCR signaling (G alpha s, PKA and ERK) )',\n",
       "  'Angiogenesis',\n",
       "  'Heterotrimeric GTP-binding protein coupled receptor signaling pathway (through G alpha i, adenylate cyclase and cAMP) ( GPCR signaling (G alpha i) )',\n",
       "  'VEGF signaling pathway',\n",
       "  'Heterotrimeric GPCR signaling pathway (through G alpha s ACs Epac BRaf and ERKcascade) ( GPCR signaling (G alpha s, Epac and ERK) )',\n",
       "  'Beta1 integrin cell surface interactions',\n",
       "  'Heterotrimeric GPCR signaling pathway (through G alpha q, PLC beta and ERK cascade) ( GPCR signaling (G alpha q) )',\n",
       "  'Heterotrimeric GTP-binding protein coupled receptor signaling pathway (through_G_alpha_s,_cholera_toxin,_adenylate_cyclase_and_cAMP) ( GPCR signaling (cholera toxin) )',\n",
       "  'VEGF signaling pathway ( VEGF signaling pathway )'],\n",
       " 'IGF2R': ['Insulin/IGF pathway-protein kinase B signaling cascade',\n",
       "  'Insulin/IGF pathway-mitogen activated protein kinase kinase/MAP kinase cascade',\n",
       "  'Apoptosis signaling pathway'],\n",
       " 'HIST1H4A': ['Signaling events mediated by HDAC Class III',\n",
       "  'Signaling events mediated by HDAC Class II',\n",
       "  'Signaling events mediated by HDAC Class I'],\n",
       " 'BTG2': ['BTG Family Proteins and Cell Cycle Regulation',\n",
       "  'Direct p53 effectors'],\n",
       " 'SERPINE1': ['Prolactin',\n",
       "  'Regulation of nuclear SMAD2/3 signaling',\n",
       "  'Plasminogen activating cascade',\n",
       "  'Direct p53 effectors',\n",
       "  'p73 transcription factor network',\n",
       "  'Blood coagulation',\n",
       "  'E2F transcription factor network',\n",
       "  'HIF-1-alpha transcription factor network',\n",
       "  'Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling',\n",
       "  'HIF-2-alpha transcription factor network',\n",
       "  'Circadian Clock',\n",
       "  'Extracellular matrix organization'],\n",
       " 'FTL': ['Transport of small molecules'],\n",
       " 'INHBA': ['ALK1 signaling events',\n",
       "  'Heterotrimeric GPCR signaling pathway (through G alpha i and pertussis toxin) ( GPCR signaling (pertussis toxin) )',\n",
       "  'Heterotrimeric GPCR signaling pathway (through_G alpha s_ACs_PKA_BRaf_and_ERKcascade)(canonical) ( GPCR signaling (G alpha s, PKA and ERK) )',\n",
       "  'TGF-beta signaling pathway',\n",
       "  'Heterotrimeric GTP-binding protein coupled receptor signaling pathway (through G alpha i, adenylate cyclase and cAMP) ( GPCR signaling (G alpha i) )',\n",
       "  'Heterotrimeric GPCR signaling pathway (through G alpha s ACs Epac BRaf and ERKcascade) ( GPCR signaling (G alpha s, Epac and ERK) )',\n",
       "  'Heterotrimeric GPCR signaling pathway (through G alpha q, PLC beta and ERK cascade) ( GPCR signaling (G alpha q) )',\n",
       "  'Heterotrimeric GTP-binding protein coupled receptor signaling pathway (through_G_alpha_s,_cholera_toxin,_adenylate_cyclase_and_cAMP) ( GPCR signaling (cholera toxin) )',\n",
       "  'untitled'],\n",
       " 'SNRPG': [],\n",
       " 'RPL27': ['Protein Synthesis: Glutamic Acid',\n",
       "  'Protein Synthesis: Isoleucine',\n",
       "  'Protein Synthesis: Serine',\n",
       "  'Protein Synthesis: Threonine',\n",
       "  'Protein Synthesis: Valine',\n",
       "  'Protein Synthesis: Alanine',\n",
       "  'Protein Synthesis: Tryptophan',\n",
       "  'Protein Synthesis: Tyrosine',\n",
       "  'Protein Synthesis: Aspartic Acid',\n",
       "  'Protein Synthesis: Methionine',\n",
       "  'Protein Synthesis: Phenylalanine',\n",
       "  'Protein Synthesis: Leucine',\n",
       "  'Protein Synthesis: Asparagine',\n",
       "  'Protein Synthesis: Glutamine',\n",
       "  'Protein Synthesis: Glycine',\n",
       "  'Protein Synthesis: Cysteine',\n",
       "  'Protein Synthesis: Arginine',\n",
       "  'Protein Synthesis: Lysine',\n",
       "  'Protein Synthesis: Histidine',\n",
       "  'Protein Synthesis: Proline'],\n",
       " 'NOS3': ['citrulline-nitric oxide cycle',\n",
       "  'Metabolic pathways',\n",
       "  'Arginine and Proline metabolism ( Arginine and Proline metabolism )',\n",
       "  'Angiopoietin receptor Tie2-mediated signaling',\n",
       "  'Ion Channels and Their Functional Role in Vascular Endothelium',\n",
       "  'VEGFR1 specific signals',\n",
       "  'Succinate Signalling During Inflammation',\n",
       "  'SHP2 signaling',\n",
       "  'EGFR1',\n",
       "  'Signaling events mediated by VEGFR1 and VEGFR2',\n",
       "  'Leptin',\n",
       "  'PAR1-mediated thrombin signaling events',\n",
       "  'Interleukin signaling pathway',\n",
       "  'PI3 kinase pathway',\n",
       "  'Angiogenesis',\n",
       "  'untitled',\n",
       "  'Validated transcriptional targets of AP1 family members Fra1 and Fra2',\n",
       "  'Plasma membrane estrogen receptor signaling',\n",
       "  'VEGF signaling pathway',\n",
       "  'Thromboxane A2 receptor signaling',\n",
       "  'Doxorubicin Metabolism Pathway',\n",
       "  'Metabolism'],\n",
       " 'FLT1': ['Glypican 1 network',\n",
       "  'VEGFR1 specific signals',\n",
       "  'Signaling events mediated by VEGFR1 and VEGFR2',\n",
       "  'Drosophila Toll-like receptor signaling ( Drosophila Toll-like receptor signaling )',\n",
       "  'VEGF and VEGFR signaling network',\n",
       "  'S1P3 pathway',\n",
       "  'HIF-2-alpha transcription factor network',\n",
       "  'VEGF signaling pathway ( VEGF signaling pathway )'],\n",
       " 'PLIN2': ['HIF-1-alpha transcription factor network'],\n",
       " 'F5': ['Aprotinin Action Pathway',\n",
       "  'Aminocaproic Acid Action Pathway',\n",
       "  'Lepirudin Action Pathway',\n",
       "  'Enoxaparin Action Pathway',\n",
       "  'Dicoumarol Action Pathway',\n",
       "  'Reteplase Action Pathway',\n",
       "  'Alteplase Action Pathway',\n",
       "  'Streptokinase Action Pathway',\n",
       "  'Ximelagatran Action Pathway',\n",
       "  'Ardeparin Action Pathway',\n",
       "  'Urokinase Action Pathway',\n",
       "  'Tenecteplase Action Pathway',\n",
       "  'Heparin Action Pathway',\n",
       "  'Warfarin Action Pathway',\n",
       "  'Phenindione Action Pathway',\n",
       "  'Coagulation',\n",
       "  'Anistreplase Action Pathway',\n",
       "  'Argatroban Action Pathway',\n",
       "  'Bivalirudin Action Pathway',\n",
       "  'Tranexamic Acid Action Pathway',\n",
       "  'Dicumarol Action Pathway',\n",
       "  'Phenprocoumon Action Pathway',\n",
       "  'Fondaparinux Action Pathway',\n",
       "  'Acenocoumarol Action Pathway'],\n",
       " 'IGF2': ['Posttranslational regulation of adherens junction stability and dissassembly',\n",
       "  'Heterotrimeric GPCR signaling pathway (through G alpha i and pertussis toxin) ( GPCR signaling (pertussis toxin) )',\n",
       "  'Heterotrimeric GPCR signaling pathway (through_G alpha s_ACs_PKA_BRaf_and_ERKcascade)(canonical) ( GPCR signaling (G alpha s, PKA and ERK) )',\n",
       "  'Insulin/IGF pathway-protein kinase B signaling cascade',\n",
       "  'Insulin/IGF pathway-mitogen activated protein kinase kinase/MAP kinase cascade',\n",
       "  'Heterotrimeric GTP-binding protein coupled receptor signaling pathway (through G alpha i, adenylate cyclase and cAMP) ( GPCR signaling (G alpha i) )',\n",
       "  'Heterotrimeric GPCR signaling pathway (through G alpha s ACs Epac BRaf and ERKcascade) ( GPCR signaling (G alpha s, Epac and ERK) )',\n",
       "  'Heterotrimeric GPCR signaling pathway (through G alpha q, PLC beta and ERK cascade) ( GPCR signaling (G alpha q) )',\n",
       "  'Heterotrimeric GTP-binding protein coupled receptor signaling pathway (through_G_alpha_s,_cholera_toxin,_adenylate_cyclase_and_cAMP) ( GPCR signaling (cholera toxin) )',\n",
       "  'Metabolism of RNA',\n",
       "  'Signaling Pathways'],\n",
       " 'UBC': ['Ubiquitin–Proteasome Pathway',\n",
       "  'NF-kB Signaling Pathway',\n",
       "  'T Cell Receptor Signaling Pathway',\n",
       "  'Circadian Clock',\n",
       "  'Metabolism of proteins'],\n",
       " 'BTNL9': [],\n",
       " 'NRIP1': ['Retinoic acid receptors-mediated signaling',\n",
       "  'FOXA1 transcription factor network',\n",
       "  'Coregulation of Androgen receptor activity',\n",
       "  'Validated nuclear estrogen receptor alpha network',\n",
       "  'AndrogenReceptor',\n",
       "  'Circadian Clock'],\n",
       " 'HPSE': ['Syndecan-1-mediated signaling events',\n",
       "  'Glycosaminoglycan degradation',\n",
       "  'Metabolic pathways'],\n",
       " 'TMSB10': [],\n",
       " 'ZNF346': [],\n",
       " 'H19': ['protein citrullination', 'Metabolism of RNA'],\n",
       " 'LYN': ['BCR signaling pathway',\n",
       "  'EPO signaling pathway',\n",
       "  'IL5-mediated signaling events',\n",
       "  'BCR Signaling Pathway',\n",
       "  'Fc-epsilon receptor I signaling in mast cells',\n",
       "  'IL8- and CXCR1-mediated signaling events',\n",
       "  'IL8- and CXCR2-mediated signaling events',\n",
       "  'B cell activation',\n",
       "  'GMCSF-mediated signaling events',\n",
       "  'LPA receptor mediated events',\n",
       "  'Signaling events mediated by Stem cell factor receptor (c-Kit)',\n",
       "  'Fc Epsilon Receptor I Signaling in Mast Cells',\n",
       "  'KitReceptor',\n",
       "  'BCR',\n",
       "  'RANKL',\n",
       "  'IL5',\n",
       "  'IL3',\n",
       "  'Prolactin',\n",
       "  'IL6',\n",
       "  'IL2',\n",
       "  'TCR',\n",
       "  'Gastrin_CCK2R_240212',\n",
       "  'Signaling events mediated by PTP1B',\n",
       "  'Glypican 1 network',\n",
       "  'CXCR4-mediated signaling events',\n",
       "  'EGFR1',\n",
       "  'EPHA forward signaling',\n",
       "  'Class I PI3K signaling events',\n",
       "  'Alpha-synuclein signaling',\n",
       "  'Parkinson disease',\n",
       "  'Cadherin signaling pathway',\n",
       "  'Ephrin B reverse signaling',\n",
       "  'PDGFR-beta signaling pathway',\n",
       "  'Thromboxane A2 receptor signaling',\n",
       "  'Regulation of p38-alpha and p38-beta',\n",
       "  'Hemostasis',\n",
       "  'Immune System',\n",
       "  'Signaling Pathways'],\n",
       " 'MYO7B': ['Nicotinic acetylcholine receptor signaling pathway'],\n",
       " 'MTHFR': ['Metabolic pathways',\n",
       "  'Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)',\n",
       "  'Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)',\n",
       "  'Hypermethioninemia',\n",
       "  'Folate Malabsorption, Hereditary',\n",
       "  'Homocystinuria-Megaloblastic Anemia Due to Defect in Cobalamin Metabolism, cblG Complementation Type',\n",
       "  'Methotrexate Action Pathway',\n",
       "  'Methionine Adenosyltransferase Deficiency',\n",
       "  'Glycine N-Methyltransferase Deficiency',\n",
       "  'Cystathionine beta-Synthase Deficiency',\n",
       "  'Folate Metabolism',\n",
       "  'S-Adenosylhomocysteine (SAH) Hydrolase Deficiency',\n",
       "  'Methionine Metabolism',\n",
       "  'Folate metabolism ( Folate metabolism )'],\n",
       " 'PLEK': [],\n",
       " 'IL4R': ['IL4-mediated signaling events',\n",
       "  'IL4',\n",
       "  'p73 transcription factor network',\n",
       "  'IL-13 signaling pathway(JAK1 TYK2 STAT6) ( IL-13 signaling(JAK1 TYK2 STAT6) )',\n",
       "  'IL-4 signaling pathway(JAK1 JAK3 STAT6) ( IL-4 signaling(JAK1 JAK3 STAT6) )',\n",
       "  'Interleukin signaling pathway',\n",
       "  'JAK-STAT pathway and regulation pathway ( JAK-STAT pathway and regulation pathway Diagram )'],\n",
       " 'C1QA': [],\n",
       " 'LEP': ['Leptin',\n",
       "  'TSH',\n",
       "  'Signaling events mediated by PTP1B',\n",
       "  'Heterotrimeric GPCR signaling pathway (through G alpha i and pertussis toxin) ( GPCR signaling (pertussis toxin) )',\n",
       "  'Heterotrimeric GPCR signaling pathway (through_G alpha s_ACs_PKA_BRaf_and_ERKcascade)(canonical) ( GPCR signaling (G alpha s, PKA and ERK) )',\n",
       "  'Heterotrimeric GTP-binding protein coupled receptor signaling pathway (through G alpha i, adenylate cyclase and cAMP) ( GPCR signaling (G alpha i) )',\n",
       "  'Heterotrimeric GPCR signaling pathway (through G alpha s ACs Epac BRaf and ERKcascade) ( GPCR signaling (G alpha s, Epac and ERK) )',\n",
       "  'HIF-1-alpha transcription factor network',\n",
       "  'Heterotrimeric GPCR signaling pathway (through G alpha q, PLC beta and ERK cascade) ( GPCR signaling (G alpha q) )',\n",
       "  'Heterotrimeric GTP-binding protein coupled receptor signaling pathway (through_G_alpha_s,_cholera_toxin,_adenylate_cyclase_and_cAMP) ( GPCR signaling (cholera toxin) )',\n",
       "  'Signaling Pathways'],\n",
       " 'CSF1': ['Signaling events mediated by PTP1B',\n",
       "  'Signaling events mediated by TCPTP',\n",
       "  'Integrins in angiogenesis'],\n",
       " 'FPR3': ['Inflammation mediated by chemokine and cytokine signaling pathway',\n",
       "  'Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling'],\n",
       " 'VEGFB': ['VEGFR1 specific signals',\n",
       "  'Heterotrimeric GPCR signaling pathway (through G alpha i and pertussis toxin) ( GPCR signaling (pertussis toxin) )',\n",
       "  'Heterotrimeric GPCR signaling pathway (through_G alpha s_ACs_PKA_BRaf_and_ERKcascade)(canonical) ( GPCR signaling (G alpha s, PKA and ERK) )',\n",
       "  'VEGF and VEGFR signaling network',\n",
       "  'Heterotrimeric GTP-binding protein coupled receptor signaling pathway (through G alpha i, adenylate cyclase and cAMP) ( GPCR signaling (G alpha i) )',\n",
       "  'Heterotrimeric GPCR signaling pathway (through G alpha s ACs Epac BRaf and ERKcascade) ( GPCR signaling (G alpha s, Epac and ERK) )',\n",
       "  'Heterotrimeric GPCR signaling pathway (through G alpha q, PLC beta and ERK cascade) ( GPCR signaling (G alpha q) )',\n",
       "  'Heterotrimeric GTP-binding protein coupled receptor signaling pathway (through_G_alpha_s,_cholera_toxin,_adenylate_cyclase_and_cAMP) ( GPCR signaling (cholera toxin) )',\n",
       "  'VEGF signaling pathway ( VEGF signaling pathway )'],\n",
       " 'EEF1B2': [],\n",
       " 'THBS4': [],\n",
       " 'ACE': ['Fosinopril Action Pathway',\n",
       "  'Spirapril Action Pathway',\n",
       "  'Perindopril Action Pathway',\n",
       "  'Cilazapril Action Pathway',\n",
       "  'Enalapril Action Pathway',\n",
       "  'Irbesartan Action Pathway',\n",
       "  'Benazepril Action Pathway',\n",
       "  'Valsartan Action Pathway',\n",
       "  'Ramipril Action Pathway',\n",
       "  'Temocapril Action Pathway',\n",
       "  'Angiotensin Metabolism',\n",
       "  'Forasartan Action Pathway',\n",
       "  'Eprosartan Action Pathway',\n",
       "  'Trandolapril Action Pathway',\n",
       "  'Quinapril Action Pathway',\n",
       "  'Olmesartan Action Pathway',\n",
       "  'Rescinnamine Action Pathway',\n",
       "  'Lisinopril Action Pathway',\n",
       "  'Losartan Action Pathway',\n",
       "  'Moexipril Action Pathway',\n",
       "  'Captopril Action Pathway',\n",
       "  'Candesartan Action Pathway',\n",
       "  'Telmisartan Action Pathway',\n",
       "  'Metabolism of proteins'],\n",
       " 'TNF': ['TNF receptor signaling pathway',\n",
       "  'HIV-1 Nef: Negative effector of Fas and TNF-alpha',\n",
       "  'Ceramide signaling pathway',\n",
       "  'TNFalpha',\n",
       "  'NF-kB Signaling Pathway',\n",
       "  'Apoptosis signaling pathway',\n",
       "  'Caspase Cascade in Apoptosis',\n",
       "  'TNF/Stress Related Signaling',\n",
       "  'RXR and RAR heterodimerization with other nuclear receptor',\n",
       "  'TNFR1 signaling pathway ( TNFR1 signaling pathway )',\n",
       "  'Canonical NF-kappaB pathway',\n",
       "  'amb2 Integrin signaling',\n",
       "  'Calcineurin-regulated NFAT-dependent transcription in lymphocytes',\n",
       "  'TWEAK',\n",
       "  'IL27-mediated signaling events',\n",
       "  'Downstream signaling in naïve CD8+ T cells',\n",
       "  'IL23-mediated signaling events',\n",
       "  'Cellular roles of Anthrax toxin',\n",
       "  'Signaling events mediated by HDAC Class I',\n",
       "  'Angiopoietin receptor Tie2-mediated signaling',\n",
       "  'Toll-Like Receptor Pathway 1',\n",
       "  'Heterotrimeric GPCR signaling pathway (through G alpha i and pertussis toxin) ( GPCR signaling (pertussis toxin) )',\n",
       "  'Heterotrimeric GPCR signaling pathway (through_G alpha s_ACs_PKA_BRaf_and_ERKcascade)(canonical) ( GPCR signaling (G alpha s, PKA and ERK) )',\n",
       "  'Heterotrimeric GTP-binding protein coupled receptor signaling pathway (through G alpha i, adenylate cyclase and cAMP) ( GPCR signaling (G alpha i) )',\n",
       "  'Heterotrimeric GPCR signaling pathway (through G alpha s ACs Epac BRaf and ERKcascade) ( GPCR signaling (G alpha s, Epac and ERK) )',\n",
       "  'Heterotrimeric GPCR signaling pathway (through G alpha q, PLC beta and ERK cascade) ( GPCR signaling (G alpha q) )',\n",
       "  'JAK-STAT pathway and regulation pathway ( JAK-STAT pathway and regulation pathway Diagram )',\n",
       "  'Heterotrimeric GTP-binding protein coupled receptor signaling pathway (through_G_alpha_s,_cholera_toxin,_adenylate_cyclase_and_cAMP) ( GPCR signaling (cholera toxin) )',\n",
       "  'CD40L Signalling Pathway',\n",
       "  'flavin biosynthesis IV (mammalian)',\n",
       "  'Toll-Like Receptor Pathway 2',\n",
       "  'Programmed Cell Death',\n",
       "  'LPS and Citrate Signaling and Inflammation',\n",
       "  'TRAIL signaling pathway',\n",
       "  'CD40/CD40L signaling',\n",
       "  'IL1',\n",
       "  'Endogenous TLR signaling',\n",
       "  'IL4',\n",
       "  'Signaling Pathways',\n",
       "  'Immune System',\n",
       "  'Disease',\n",
       "  'Hemostasis',\n",
       "  'Extracellular matrix organization'],\n",
       " 'EPHX2': ['Arachidonic acid metabolism',\n",
       "  'Metabolic pathways',\n",
       "  'Diflunisal Action Pathway',\n",
       "  'Acetaminophen Action Pathway',\n",
       "  'Phenylbutazone Action Pathway',\n",
       "  'Salicylic Acid Action Pathway',\n",
       "  'Salsalate Action Pathway',\n",
       "  'Lornoxicam Action Pathway',\n",
       "  'Flurbiprofen Action Pathway',\n",
       "  'Lumiracoxib Action Pathway',\n",
       "  'Fenoprofen Action Pathway',\n",
       "  'Etoricoxib Action Pathway',\n",
       "  'Tiaprofenic Acid Action Pathway',\n",
       "  'Nepafenac Action Pathway',\n",
       "  'Tenoxicam Action Pathway',\n",
       "  'Magnesium Salicylate Action Pathway',\n",
       "  'Salicylate-Sodium Action Pathway',\n",
       "  'Antipyrine Action Pathway',\n",
       "  'Antrafenine Action Pathway',\n",
       "  'Leukotriene C4 Synthesis Deficiency',\n",
       "  'Naproxen Action Pathway',\n",
       "  'Oxaprozin Action Pathway',\n",
       "  'Diclofenac Action Pathway',\n",
       "  'Mefenamic Acid Action Pathway',\n",
       "  'Ketoprofen Action Pathway',\n",
       "  'Rofecoxib Action Pathway',\n",
       "  'Bromfenac Action Pathway',\n",
       "  'Arachidonic Acid Metabolism',\n",
       "  'Sulindac Action Pathway',\n",
       "  'Acetylsalicylic Acid Action Pathway',\n",
       "  'Indomethacin Action Pathway',\n",
       "  'Suprofen Action Pathway',\n",
       "  'Etodolac Action Pathway',\n",
       "  'Meloxicam Action Pathway',\n",
       "  'Nabumetone Action Pathway',\n",
       "  'Celecoxib Action Pathway',\n",
       "  'Valdecoxib Action Pathway',\n",
       "  'Piroxicam Action Pathway',\n",
       "  'Trisalicylate-Choline Action Pathway',\n",
       "  'Ibuprofen Action Pathway',\n",
       "  'Tolmetin Action Pathway',\n",
       "  'Ketorolac Action Pathway',\n",
       "  'Carprofen Action Pathway'],\n",
       " 'APOE': ['Disease', 'Hemostasis', 'Metabolism of proteins'],\n",
       " 'CCSAP': [],\n",
       " 'VEGFC': ['VEGF and VEGFR signaling network',\n",
       "  'VEGFR3 signaling in lymphatic endothelium',\n",
       "  'Alpha9 beta1 integrin signaling events',\n",
       "  'Heterotrimeric GPCR signaling pathway (through G alpha i and pertussis toxin) ( GPCR signaling (pertussis toxin) )',\n",
       "  'Heterotrimeric GPCR signaling pathway (through_G alpha s_ACs_PKA_BRaf_and_ERKcascade)(canonical) ( GPCR signaling (G alpha s, PKA and ERK) )',\n",
       "  'Heterotrimeric GTP-binding protein coupled receptor signaling pathway (through G alpha i, adenylate cyclase and cAMP) ( GPCR signaling (G alpha i) )',\n",
       "  'Heterotrimeric GPCR signaling pathway (through G alpha s ACs Epac BRaf and ERKcascade) ( GPCR signaling (G alpha s, Epac and ERK) )',\n",
       "  'Heterotrimeric GPCR signaling pathway (through G alpha q, PLC beta and ERK cascade) ( GPCR signaling (G alpha q) )',\n",
       "  'Heterotrimeric GTP-binding protein coupled receptor signaling pathway (through_G_alpha_s,_cholera_toxin,_adenylate_cyclase_and_cAMP) ( GPCR signaling (cholera toxin) )',\n",
       "  'VEGF signaling pathway ( VEGF signaling pathway )'],\n",
       " 'IGF1': ['IGF1 pathway',\n",
       "  'IGF1 signaling pathway ( IGF1 signaling pathway )',\n",
       "  'Integrins in angiogenesis',\n",
       "  'Stabilization and expansion of the E-cadherin adherens junction',\n",
       "  'Plasma membrane estrogen receptor signaling',\n",
       "  'Ceramide signaling pathway',\n",
       "  'SHP2 signaling',\n",
       "  'Heterotrimeric GPCR signaling pathway (through G alpha i and pertussis toxin) ( GPCR signaling (pertussis toxin) )',\n",
       "  'Heterotrimeric GPCR signaling pathway (through_G alpha s_ACs_PKA_BRaf_and_ERKcascade)(canonical) ( GPCR signaling (G alpha s, PKA and ERK) )',\n",
       "  'Insulin/IGF pathway-protein kinase B signaling cascade',\n",
       "  'Insulin/IGF pathway-mitogen activated protein kinase kinase/MAP kinase cascade',\n",
       "  'Heterotrimeric GTP-binding protein coupled receptor signaling pathway (through G alpha i, adenylate cyclase and cAMP) ( GPCR signaling (G alpha i) )',\n",
       "  'Heterotrimeric GPCR signaling pathway (through G alpha s ACs Epac BRaf and ERKcascade) ( GPCR signaling (G alpha s, Epac and ERK) )',\n",
       "  'Heterotrimeric GPCR signaling pathway (through G alpha q, PLC beta and ERK cascade) ( GPCR signaling (G alpha q) )',\n",
       "  'Heterotrimeric GTP-binding protein coupled receptor signaling pathway (through_G_alpha_s,_cholera_toxin,_adenylate_cyclase_and_cAMP) ( GPCR signaling (cholera toxin) )',\n",
       "  'Developmental Biology',\n",
       "  'Signaling Pathways'],\n",
       " 'ITGB3': ['TGF_beta_Receptor',\n",
       "  'Signaling events mediated by PTP1B',\n",
       "  'Beta3 integrin cell surface interactions',\n",
       "  'Signaling events mediated by VEGFR1 and VEGFR2',\n",
       "  'Integrin signaling pathway ( Integrin signaling pathway )',\n",
       "  'Integrins in angiogenesis',\n",
       "  'Arf6 signaling events',\n",
       "  'Nectin adhesion pathway',\n",
       "  'IL4-mediated signaling events',\n",
       "  'Ephrin B reverse signaling',\n",
       "  'PDGFR-beta signaling pathway',\n",
       "  'Integrin family cell surface interactions',\n",
       "  'Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling',\n",
       "  'Osteopontin-mediated events'],\n",
       " 'RPL26': ['Protein Synthesis: Glutamic Acid',\n",
       "  'Protein Synthesis: Isoleucine',\n",
       "  'Protein Synthesis: Serine',\n",
       "  'Protein Synthesis: Threonine',\n",
       "  'Protein Synthesis: Valine',\n",
       "  'Protein Synthesis: Alanine',\n",
       "  'Protein Synthesis: Tryptophan',\n",
       "  'Protein Synthesis: Tyrosine',\n",
       "  'Protein Synthesis: Aspartic Acid',\n",
       "  'Protein Synthesis: Methionine',\n",
       "  'Protein Synthesis: Phenylalanine',\n",
       "  'Protein Synthesis: Leucine',\n",
       "  'Protein Synthesis: Asparagine',\n",
       "  'Protein Synthesis: Glutamine',\n",
       "  'Protein Synthesis: Glycine',\n",
       "  'Protein Synthesis: Cysteine',\n",
       "  'Protein Synthesis: Arginine',\n",
       "  'Protein Synthesis: Lysine',\n",
       "  'Protein Synthesis: Histidine',\n",
       "  'Protein Synthesis: Proline']}"
      ]
     },
     "execution_count": 4,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "d = {}\n",
    "for g in tqdm(genes):\n",
    "    d[g] = re.findall(r'\"name\":\"(.*?)\",\"dataSource\":', requests.get(\"https://www.pathwaycommons.org/pc2/top_pathways?q=\" + g).text)\n",
    "d"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "This is backwards from what we need though - what we need is a dictionary that maps pathways to genes, not genes to pathways, so we create the `pathways_to_genes` dict"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'BCR signaling pathway': ['SH3BP5', 'LYN'],\n",
       " 'Extracellular matrix organization': ['FN1', 'SERPINE1', 'TNF'],\n",
       " 'Beta3 integrin cell surface interactions': ['FN1', 'VEGFA', 'ITGB3'],\n",
       " 'Angiopoietin receptor Tie2-mediated signaling': ['FN1', 'NOS3', 'TNF'],\n",
       " 'Alpha4 beta1 integrin signaling events': ['FN1'],\n",
       " 'Syndecan-4-mediated signaling events': ['FN1'],\n",
       " 'Integrin signaling pathway ( Integrin signaling pathway )': ['FN1', 'ITGB3'],\n",
       " 'VEGFR3 signaling in lymphatic endothelium': ['FN1', 'VEGFC'],\n",
       " 'Integrins in angiogenesis': ['FN1', 'VEGFA', 'CSF1', 'IGF1', 'ITGB3'],\n",
       " 'Beta5 beta6 beta7 and beta8 integrin cell surface interactions': ['FN1'],\n",
       " 'Integrin signalling pathway': ['FN1'],\n",
       " 'Beta1 integrin cell surface interactions': ['FN1', 'VEGFA'],\n",
       " 'Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling': ['FN1',\n",
       "  'SERPINE1',\n",
       "  'FPR3',\n",
       "  'ITGB3'],\n",
       " 'Syndecan-2-mediated signaling events': ['FN1'],\n",
       " 'Alpha9 beta1 integrin signaling events': ['FN1', 'VEGFA', 'VEGFC'],\n",
       " 'Hemostasis': ['FN1', 'LYN', 'TNF', 'APOE'],\n",
       " 'Protein Synthesis: Glutamic Acid': ['RPL34',\n",
       "  'RPL17',\n",
       "  'RPL23',\n",
       "  'RPS29',\n",
       "  'FAU',\n",
       "  'RPL31',\n",
       "  'RPL27',\n",
       "  'RPL26'],\n",
       " 'Protein Synthesis: Isoleucine': ['RPL34',\n",
       "  'RPL17',\n",
       "  'RPL23',\n",
       "  'RPS29',\n",
       "  'FAU',\n",
       "  'RPL31',\n",
       "  'RPL27',\n",
       "  'RPL26'],\n",
       " 'Protein Synthesis: Serine': ['RPL34',\n",
       "  'RPL17',\n",
       "  'RPL23',\n",
       "  'RPS29',\n",
       "  'FAU',\n",
       "  'RPL31',\n",
       "  'RPL27',\n",
       "  'RPL26'],\n",
       " 'Protein Synthesis: Threonine': ['RPL34',\n",
       "  'RPL17',\n",
       "  'RPL23',\n",
       "  'RPS29',\n",
       "  'FAU',\n",
       "  'RPL31',\n",
       "  'RPL27',\n",
       "  'RPL26'],\n",
       " 'Protein Synthesis: Valine': ['RPL34',\n",
       "  'RPL17',\n",
       "  'RPL23',\n",
       "  'RPS29',\n",
       "  'FAU',\n",
       "  'RPL31',\n",
       "  'RPL27',\n",
       "  'RPL26'],\n",
       " 'Protein Synthesis: Alanine': ['RPL34',\n",
       "  'RPL17',\n",
       "  'RPL23',\n",
       "  'RPS29',\n",
       "  'FAU',\n",
       "  'RPL31',\n",
       "  'RPL27',\n",
       "  'RPL26'],\n",
       " 'Protein Synthesis: Tryptophan': ['RPL34',\n",
       "  'RPL17',\n",
       "  'RPL23',\n",
       "  'RPS29',\n",
       "  'FAU',\n",
       "  'RPL31',\n",
       "  'RPL27',\n",
       "  'RPL26'],\n",
       " 'Protein Synthesis: Tyrosine': ['RPL34',\n",
       "  'RPL17',\n",
       "  'RPL23',\n",
       "  'RPS29',\n",
       "  'FAU',\n",
       "  'RPL31',\n",
       "  'RPL27',\n",
       "  'RPL26'],\n",
       " 'Protein Synthesis: Aspartic Acid': ['RPL34',\n",
       "  'RPL17',\n",
       "  'RPL23',\n",
       "  'RPS29',\n",
       "  'FAU',\n",
       "  'RPL31',\n",
       "  'RPL27',\n",
       "  'RPL26'],\n",
       " 'Protein Synthesis: Methionine': ['RPL34',\n",
       "  'RPL17',\n",
       "  'RPL23',\n",
       "  'RPS29',\n",
       "  'FAU',\n",
       "  'RPL31',\n",
       "  'RPL27',\n",
       "  'RPL26'],\n",
       " 'Protein Synthesis: Phenylalanine': ['RPL34',\n",
       "  'RPL17',\n",
       "  'RPL23',\n",
       "  'RPS29',\n",
       "  'FAU',\n",
       "  'RPL31',\n",
       "  'RPL27',\n",
       "  'RPL26'],\n",
       " 'Protein Synthesis: Leucine': ['RPL34',\n",
       "  'RPL17',\n",
       "  'RPL23',\n",
       "  'RPS29',\n",
       "  'FAU',\n",
       "  'RPL31',\n",
       "  'RPL27',\n",
       "  'RPL26'],\n",
       " 'Protein Synthesis: Asparagine': ['RPL34',\n",
       "  'RPL17',\n",
       "  'RPL23',\n",
       "  'RPS29',\n",
       "  'FAU',\n",
       "  'RPL31',\n",
       "  'RPL27',\n",
       "  'RPL26'],\n",
       " 'Protein Synthesis: Glutamine': ['RPL34',\n",
       "  'RPL17',\n",
       "  'RPL23',\n",
       "  'RPS29',\n",
       "  'FAU',\n",
       "  'RPL31',\n",
       "  'RPL27',\n",
       "  'RPL26'],\n",
       " 'Protein Synthesis: Glycine': ['RPL34',\n",
       "  'RPL17',\n",
       "  'RPL23',\n",
       "  'RPS29',\n",
       "  'FAU',\n",
       "  'RPL31',\n",
       "  'RPL27',\n",
       "  'RPL26'],\n",
       " 'Protein Synthesis: Cysteine': ['RPL34',\n",
       "  'RPL17',\n",
       "  'RPL23',\n",
       "  'RPS29',\n",
       "  'FAU',\n",
       "  'RPL31',\n",
       "  'RPL27',\n",
       "  'RPL26'],\n",
       " 'Protein Synthesis: Arginine': ['RPL34',\n",
       "  'RPL17',\n",
       "  'RPL23',\n",
       "  'RPS29',\n",
       "  'FAU',\n",
       "  'RPL31',\n",
       "  'RPL27',\n",
       "  'RPL26'],\n",
       " 'Protein Synthesis: Lysine': ['RPL34',\n",
       "  'RPL17',\n",
       "  'RPL23',\n",
       "  'RPS29',\n",
       "  'FAU',\n",
       "  'RPL31',\n",
       "  'RPL27',\n",
       "  'RPL26'],\n",
       " 'Protein Synthesis: Histidine': ['RPL34',\n",
       "  'RPL17',\n",
       "  'RPL23',\n",
       "  'RPS29',\n",
       "  'FAU',\n",
       "  'RPL31',\n",
       "  'RPL27',\n",
       "  'RPL26'],\n",
       " 'Protein Synthesis: Proline': ['RPL34',\n",
       "  'RPL17',\n",
       "  'RPL23',\n",
       "  'RPS29',\n",
       "  'FAU',\n",
       "  'RPL31',\n",
       "  'RPL27',\n",
       "  'RPL26'],\n",
       " 'Metabolism of xenobiotics by cytochrome P450': ['EPHX1', 'GSTP1'],\n",
       " 'Phenytoin (Antiarrhythmic) Action Pathway': ['EPHX1'],\n",
       " 'Carbamazepine Metabolism Pathway': ['EPHX1'],\n",
       " 'Aurora B signaling': ['NPM1'],\n",
       " 'Validated targets of C-MYC transcriptional activation': ['NPM1'],\n",
       " 'HIF-1-alpha transcription factor network': ['NPM1',\n",
       "  'HK2',\n",
       "  'NDRG1',\n",
       "  'BHLHE40',\n",
       "  'VEGFA',\n",
       "  'SERPINE1',\n",
       "  'PLIN2',\n",
       "  'LEP'],\n",
       " '4-hydroxy-2-nonenal detoxification': ['GSTP1'],\n",
       " 'glutathione-mediated detoxification I': ['GSTP1'],\n",
       " 'Drug metabolism - cytochrome P450': ['GSTP1'],\n",
       " 'Acetaminophen Metabolism Pathway': ['GSTP1'],\n",
       " 'p53 pathway': ['RPL23'],\n",
       " 'VEGFR1 specific signals': ['PGF', 'VEGFA', 'NOS3', 'FLT1', 'VEGFB'],\n",
       " 'VEGF and VEGFR signaling network': ['PGF',\n",
       "  'VEGFA',\n",
       "  'FLT1',\n",
       "  'VEGFB',\n",
       "  'VEGFC'],\n",
       " 'Metabolic pathways': ['HK2', 'NOS3', 'HPSE', 'MTHFR', 'EPHX2'],\n",
       " 'Triosephosphate Isomerase Deficiency': ['HK2'],\n",
       " 'Fanconi-Bickel Syndrome': ['HK2'],\n",
       " 'Glycogenosis, Type III. Cori Disease, Debrancher Glycogenosis': ['HK2'],\n",
       " 'Glycogenosis, Type IA. Von Gierke Disease': ['HK2'],\n",
       " 'Mucopolysaccharidosis VII. Sly Syndrome': ['HK2'],\n",
       " 'Glycogenosis, Type IB': ['HK2'],\n",
       " 'Glycogenosis, Type VII. Tarui Disease': ['HK2'],\n",
       " 'Phosphoenolpyruvate Carboxykinase Deficiency 1 (PEPCK1)': ['HK2'],\n",
       " 'Glycogenosis, Type VI. Hers Disease': ['HK2'],\n",
       " 'Sucrase-Isomaltase Deficiency': ['HK2'],\n",
       " 'Glycogen Synthetase Deficiency': ['HK2'],\n",
       " 'Glycogenosis, Type IC': ['HK2'],\n",
       " 'Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease': ['HK2'],\n",
       " 'Gluconeogenesis': ['HK2'],\n",
       " 'Glycolysis': ['HK2', 'HK2'],\n",
       " 'Fructose galactose metabolism': ['HK2'],\n",
       " 'Glycolysis and Gluconeogenesis ( Glycolysis and Gluconeogenesis )': ['HK2'],\n",
       " 'Pentose phosphate pathway': ['HK2'],\n",
       " 'Aminosugars metabolism ( Aminosugars metabolism )': ['HK2'],\n",
       " 'Fructose and Mannose metabolism ( Fructose and Mannose metabolism )': ['HK2'],\n",
       " 'Starch and Sucrose Metabolism': ['HK2'],\n",
       " 'Warburg Effect': ['HK2'],\n",
       " 'Fructose-1,6-diphosphatase Deficiency': ['HK2'],\n",
       " 'Glycogenosis, Type IV. Amylopectinosis, Anderson Disease': ['HK2'],\n",
       " 'Validated targets of C-MYC transcriptional repression': ['NDRG1'],\n",
       " 'Direct p53 effectors': ['NDRG1', 'BTG2', 'SERPINE1'],\n",
       " 'Cytoskeletal regulation by Rho GTPase': ['TUBB6'],\n",
       " 'Huntington disease': ['TUBB6'],\n",
       " 'EGFR1': ['EEF1A1', 'NOS3', 'LYN'],\n",
       " 'Autophagy': ['EEF1A1'],\n",
       " 'Cellular responses to external stimuli': ['EEF1A1'],\n",
       " 'Classical Complement Pathway': ['C1QB'],\n",
       " 'Complement Pathway': ['C1QB'],\n",
       " 'Fanconi anemia pathway': ['BHLHE40'],\n",
       " 'Circadian rhythm pathway': ['BHLHE40'],\n",
       " 'HIF-2-alpha transcription factor network': ['BHLHE40',\n",
       "  'VEGFA',\n",
       "  'SERPINE1',\n",
       "  'FLT1'],\n",
       " 'Circadian Clock': ['BHLHE40', 'SERPINE1', 'UBC', 'NRIP1'],\n",
       " 'Gene expression (Transcription)': ['TET3'],\n",
       " 'Signaling events mediated by VEGFR1 and VEGFR2': ['VEGFA',\n",
       "  'NOS3',\n",
       "  'FLT1',\n",
       "  'ITGB3'],\n",
       " 'S1P1 pathway': ['VEGFA'],\n",
       " 'Signaling events mediated by TCPTP': ['VEGFA', 'CSF1'],\n",
       " 'S1P3 pathway': ['VEGFA', 'FLT1'],\n",
       " 'Plexin-D1 Signaling': ['VEGFA'],\n",
       " 'SHP2 signaling': ['VEGFA', 'NOS3', 'IGF1'],\n",
       " 'Glypican 1 network': ['VEGFA', 'FLT1', 'LYN'],\n",
       " 'Heterotrimeric GPCR signaling pathway (through G alpha i and pertussis toxin) ( GPCR signaling (pertussis toxin) )': ['VEGFA',\n",
       "  'INHBA',\n",
       "  'IGF2',\n",
       "  'LEP',\n",
       "  'VEGFB',\n",
       "  'TNF',\n",
       "  'VEGFC',\n",
       "  'IGF1'],\n",
       " 'Heterotrimeric GPCR signaling pathway (through_G alpha s_ACs_PKA_BRaf_and_ERKcascade)(canonical) ( GPCR signaling (G alpha s, PKA and ERK) )': ['VEGFA',\n",
       "  'INHBA',\n",
       "  'IGF2',\n",
       "  'LEP',\n",
       "  'VEGFB',\n",
       "  'TNF',\n",
       "  'VEGFC',\n",
       "  'IGF1'],\n",
       " 'Angiogenesis': ['VEGFA', 'NOS3'],\n",
       " 'Heterotrimeric GTP-binding protein coupled receptor signaling pathway (through G alpha i, adenylate cyclase and cAMP) ( GPCR signaling (G alpha i) )': ['VEGFA',\n",
       "  'INHBA',\n",
       "  'IGF2',\n",
       "  'LEP',\n",
       "  'VEGFB',\n",
       "  'TNF',\n",
       "  'VEGFC',\n",
       "  'IGF1'],\n",
       " 'VEGF signaling pathway': ['VEGFA', 'NOS3'],\n",
       " 'Heterotrimeric GPCR signaling pathway (through G alpha s ACs Epac BRaf and ERKcascade) ( GPCR signaling (G alpha s, Epac and ERK) )': ['VEGFA',\n",
       "  'INHBA',\n",
       "  'IGF2',\n",
       "  'LEP',\n",
       "  'VEGFB',\n",
       "  'TNF',\n",
       "  'VEGFC',\n",
       "  'IGF1'],\n",
       " 'Heterotrimeric GPCR signaling pathway (through G alpha q, PLC beta and ERK cascade) ( GPCR signaling (G alpha q) )': ['VEGFA',\n",
       "  'INHBA',\n",
       "  'IGF2',\n",
       "  'LEP',\n",
       "  'VEGFB',\n",
       "  'TNF',\n",
       "  'VEGFC',\n",
       "  'IGF1'],\n",
       " 'Heterotrimeric GTP-binding protein coupled receptor signaling pathway (through_G_alpha_s,_cholera_toxin,_adenylate_cyclase_and_cAMP) ( GPCR signaling (cholera toxin) )': ['VEGFA',\n",
       "  'INHBA',\n",
       "  'IGF2',\n",
       "  'LEP',\n",
       "  'VEGFB',\n",
       "  'TNF',\n",
       "  'VEGFC',\n",
       "  'IGF1'],\n",
       " 'VEGF signaling pathway ( VEGF signaling pathway )': ['VEGFA',\n",
       "  'FLT1',\n",
       "  'VEGFB',\n",
       "  'VEGFC'],\n",
       " 'Insulin/IGF pathway-protein kinase B signaling cascade': ['IGF2R',\n",
       "  'IGF2',\n",
       "  'IGF1'],\n",
       " 'Insulin/IGF pathway-mitogen activated protein kinase kinase/MAP kinase cascade': ['IGF2R',\n",
       "  'IGF2',\n",
       "  'IGF1'],\n",
       " 'Apoptosis signaling pathway': ['IGF2R', 'TNF'],\n",
       " 'Signaling events mediated by HDAC Class III': ['HIST1H4A'],\n",
       " 'Signaling events mediated by HDAC Class II': ['HIST1H4A'],\n",
       " 'Signaling events mediated by HDAC Class I': ['HIST1H4A', 'TNF'],\n",
       " 'BTG Family Proteins and Cell Cycle Regulation': ['BTG2'],\n",
       " 'Prolactin': ['SERPINE1', 'LYN'],\n",
       " 'Regulation of nuclear SMAD2/3 signaling': ['SERPINE1'],\n",
       " 'Plasminogen activating cascade': ['SERPINE1'],\n",
       " 'p73 transcription factor network': ['SERPINE1', 'IL4R'],\n",
       " 'Blood coagulation': ['SERPINE1'],\n",
       " 'E2F transcription factor network': ['SERPINE1'],\n",
       " 'Transport of small molecules': ['FTL'],\n",
       " 'ALK1 signaling events': ['INHBA'],\n",
       " 'TGF-beta signaling pathway': ['INHBA'],\n",
       " 'untitled': ['INHBA', 'NOS3'],\n",
       " 'citrulline-nitric oxide cycle': ['NOS3'],\n",
       " 'Arginine and Proline metabolism ( Arginine and Proline metabolism )': ['NOS3'],\n",
       " 'Ion Channels and Their Functional Role in Vascular Endothelium': ['NOS3'],\n",
       " 'Succinate Signalling During Inflammation': ['NOS3'],\n",
       " 'Leptin': ['NOS3', 'LEP'],\n",
       " 'PAR1-mediated thrombin signaling events': ['NOS3'],\n",
       " 'Interleukin signaling pathway': ['NOS3', 'IL4R'],\n",
       " 'PI3 kinase pathway': ['NOS3'],\n",
       " 'Validated transcriptional targets of AP1 family members Fra1 and Fra2': ['NOS3'],\n",
       " 'Plasma membrane estrogen receptor signaling': ['NOS3', 'IGF1'],\n",
       " 'Thromboxane A2 receptor signaling': ['NOS3', 'LYN'],\n",
       " 'Doxorubicin Metabolism Pathway': ['NOS3'],\n",
       " 'Metabolism': ['NOS3'],\n",
       " 'Drosophila Toll-like receptor signaling ( Drosophila Toll-like receptor signaling )': ['FLT1'],\n",
       " 'Aprotinin Action Pathway': ['F5'],\n",
       " 'Aminocaproic Acid Action Pathway': ['F5'],\n",
       " 'Lepirudin Action Pathway': ['F5'],\n",
       " 'Enoxaparin Action Pathway': ['F5'],\n",
       " 'Dicoumarol Action Pathway': ['F5'],\n",
       " 'Reteplase Action Pathway': ['F5'],\n",
       " 'Alteplase Action Pathway': ['F5'],\n",
       " 'Streptokinase Action Pathway': ['F5'],\n",
       " 'Ximelagatran Action Pathway': ['F5'],\n",
       " 'Ardeparin Action Pathway': ['F5'],\n",
       " 'Urokinase Action Pathway': ['F5'],\n",
       " 'Tenecteplase Action Pathway': ['F5'],\n",
       " 'Heparin Action Pathway': ['F5'],\n",
       " 'Warfarin Action Pathway': ['F5'],\n",
       " 'Phenindione Action Pathway': ['F5'],\n",
       " 'Coagulation': ['F5'],\n",
       " 'Anistreplase Action Pathway': ['F5'],\n",
       " 'Argatroban Action Pathway': ['F5'],\n",
       " 'Bivalirudin Action Pathway': ['F5'],\n",
       " 'Tranexamic Acid Action Pathway': ['F5'],\n",
       " 'Dicumarol Action Pathway': ['F5'],\n",
       " 'Phenprocoumon Action Pathway': ['F5'],\n",
       " 'Fondaparinux Action Pathway': ['F5'],\n",
       " 'Acenocoumarol Action Pathway': ['F5'],\n",
       " 'Posttranslational regulation of adherens junction stability and dissassembly': ['IGF2'],\n",
       " 'Metabolism of RNA': ['IGF2', 'H19'],\n",
       " 'Signaling Pathways': ['IGF2', 'LYN', 'LEP', 'TNF', 'IGF1'],\n",
       " 'Ubiquitin–Proteasome Pathway': ['UBC'],\n",
       " 'NF-kB Signaling Pathway': ['UBC', 'TNF'],\n",
       " 'T Cell Receptor Signaling Pathway': ['UBC'],\n",
       " 'Metabolism of proteins': ['UBC', 'ACE', 'APOE'],\n",
       " 'Retinoic acid receptors-mediated signaling': ['NRIP1'],\n",
       " 'FOXA1 transcription factor network': ['NRIP1'],\n",
       " 'Coregulation of Androgen receptor activity': ['NRIP1'],\n",
       " 'Validated nuclear estrogen receptor alpha network': ['NRIP1'],\n",
       " 'AndrogenReceptor': ['NRIP1'],\n",
       " 'Syndecan-1-mediated signaling events': ['HPSE'],\n",
       " 'Glycosaminoglycan degradation': ['HPSE'],\n",
       " 'protein citrullination': ['H19'],\n",
       " 'EPO signaling pathway': ['LYN'],\n",
       " 'IL5-mediated signaling events': ['LYN'],\n",
       " 'BCR Signaling Pathway': ['LYN'],\n",
       " 'Fc-epsilon receptor I signaling in mast cells': ['LYN'],\n",
       " 'IL8- and CXCR1-mediated signaling events': ['LYN'],\n",
       " 'IL8- and CXCR2-mediated signaling events': ['LYN'],\n",
       " 'B cell activation': ['LYN'],\n",
       " 'GMCSF-mediated signaling events': ['LYN'],\n",
       " 'LPA receptor mediated events': ['LYN'],\n",
       " 'Signaling events mediated by Stem cell factor receptor (c-Kit)': ['LYN'],\n",
       " 'Fc Epsilon Receptor I Signaling in Mast Cells': ['LYN'],\n",
       " 'KitReceptor': ['LYN'],\n",
       " 'BCR': ['LYN'],\n",
       " 'RANKL': ['LYN'],\n",
       " 'IL5': ['LYN'],\n",
       " 'IL3': ['LYN'],\n",
       " 'IL6': ['LYN'],\n",
       " 'IL2': ['LYN'],\n",
       " 'TCR': ['LYN'],\n",
       " 'Gastrin_CCK2R_240212': ['LYN'],\n",
       " 'Signaling events mediated by PTP1B': ['LYN', 'LEP', 'CSF1', 'ITGB3'],\n",
       " 'CXCR4-mediated signaling events': ['LYN'],\n",
       " 'EPHA forward signaling': ['LYN'],\n",
       " 'Class I PI3K signaling events': ['LYN'],\n",
       " 'Alpha-synuclein signaling': ['LYN'],\n",
       " 'Parkinson disease': ['LYN'],\n",
       " 'Cadherin signaling pathway': ['LYN'],\n",
       " 'Ephrin B reverse signaling': ['LYN', 'ITGB3'],\n",
       " 'PDGFR-beta signaling pathway': ['LYN', 'ITGB3'],\n",
       " 'Regulation of p38-alpha and p38-beta': ['LYN'],\n",
       " 'Immune System': ['LYN', 'TNF'],\n",
       " 'Nicotinic acetylcholine receptor signaling pathway': ['MYO7B'],\n",
       " 'Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)': ['MTHFR', 'MTHFR'],\n",
       " 'Hypermethioninemia': ['MTHFR'],\n",
       " 'Folate Malabsorption, Hereditary': ['MTHFR'],\n",
       " 'Homocystinuria-Megaloblastic Anemia Due to Defect in Cobalamin Metabolism, cblG Complementation Type': ['MTHFR'],\n",
       " 'Methotrexate Action Pathway': ['MTHFR'],\n",
       " 'Methionine Adenosyltransferase Deficiency': ['MTHFR'],\n",
       " 'Glycine N-Methyltransferase Deficiency': ['MTHFR'],\n",
       " 'Cystathionine beta-Synthase Deficiency': ['MTHFR'],\n",
       " 'Folate Metabolism': ['MTHFR'],\n",
       " 'S-Adenosylhomocysteine (SAH) Hydrolase Deficiency': ['MTHFR'],\n",
       " 'Methionine Metabolism': ['MTHFR'],\n",
       " 'Folate metabolism ( Folate metabolism )': ['MTHFR'],\n",
       " 'IL4-mediated signaling events': ['IL4R', 'ITGB3'],\n",
       " 'IL4': ['IL4R', 'TNF'],\n",
       " 'IL-13 signaling pathway(JAK1 TYK2 STAT6) ( IL-13 signaling(JAK1 TYK2 STAT6) )': ['IL4R'],\n",
       " 'IL-4 signaling pathway(JAK1 JAK3 STAT6) ( IL-4 signaling(JAK1 JAK3 STAT6) )': ['IL4R'],\n",
       " 'JAK-STAT pathway and regulation pathway ( JAK-STAT pathway and regulation pathway Diagram )': ['IL4R',\n",
       "  'TNF'],\n",
       " 'TSH': ['LEP'],\n",
       " 'Inflammation mediated by chemokine and cytokine signaling pathway': ['FPR3'],\n",
       " 'Fosinopril Action Pathway': ['ACE'],\n",
       " 'Spirapril Action Pathway': ['ACE'],\n",
       " 'Perindopril Action Pathway': ['ACE'],\n",
       " 'Cilazapril Action Pathway': ['ACE'],\n",
       " 'Enalapril Action Pathway': ['ACE'],\n",
       " 'Irbesartan Action Pathway': ['ACE'],\n",
       " 'Benazepril Action Pathway': ['ACE'],\n",
       " 'Valsartan Action Pathway': ['ACE'],\n",
       " 'Ramipril Action Pathway': ['ACE'],\n",
       " 'Temocapril Action Pathway': ['ACE'],\n",
       " 'Angiotensin Metabolism': ['ACE'],\n",
       " 'Forasartan Action Pathway': ['ACE'],\n",
       " 'Eprosartan Action Pathway': ['ACE'],\n",
       " 'Trandolapril Action Pathway': ['ACE'],\n",
       " 'Quinapril Action Pathway': ['ACE'],\n",
       " 'Olmesartan Action Pathway': ['ACE'],\n",
       " 'Rescinnamine Action Pathway': ['ACE'],\n",
       " 'Lisinopril Action Pathway': ['ACE'],\n",
       " 'Losartan Action Pathway': ['ACE'],\n",
       " 'Moexipril Action Pathway': ['ACE'],\n",
       " 'Captopril Action Pathway': ['ACE'],\n",
       " 'Candesartan Action Pathway': ['ACE'],\n",
       " 'Telmisartan Action Pathway': ['ACE'],\n",
       " 'TNF receptor signaling pathway': ['TNF'],\n",
       " 'HIV-1 Nef: Negative effector of Fas and TNF-alpha': ['TNF'],\n",
       " 'Ceramide signaling pathway': ['TNF', 'IGF1'],\n",
       " 'TNFalpha': ['TNF'],\n",
       " 'Caspase Cascade in Apoptosis': ['TNF'],\n",
       " 'TNF/Stress Related Signaling': ['TNF'],\n",
       " 'RXR and RAR heterodimerization with other nuclear receptor': ['TNF'],\n",
       " 'TNFR1 signaling pathway ( TNFR1 signaling pathway )': ['TNF'],\n",
       " 'Canonical NF-kappaB pathway': ['TNF'],\n",
       " 'amb2 Integrin signaling': ['TNF'],\n",
       " 'Calcineurin-regulated NFAT-dependent transcription in lymphocytes': ['TNF'],\n",
       " 'TWEAK': ['TNF'],\n",
       " 'IL27-mediated signaling events': ['TNF'],\n",
       " 'Downstream signaling in naïve CD8+ T cells': ['TNF'],\n",
       " 'IL23-mediated signaling events': ['TNF'],\n",
       " 'Cellular roles of Anthrax toxin': ['TNF'],\n",
       " 'Toll-Like Receptor Pathway 1': ['TNF'],\n",
       " 'CD40L Signalling Pathway': ['TNF'],\n",
       " 'flavin biosynthesis IV (mammalian)': ['TNF'],\n",
       " 'Toll-Like Receptor Pathway 2': ['TNF'],\n",
       " 'Programmed Cell Death': ['TNF'],\n",
       " 'LPS and Citrate Signaling and Inflammation': ['TNF'],\n",
       " 'TRAIL signaling pathway': ['TNF'],\n",
       " 'CD40/CD40L signaling': ['TNF'],\n",
       " 'IL1': ['TNF'],\n",
       " 'Endogenous TLR signaling': ['TNF'],\n",
       " 'Disease': ['TNF', 'APOE'],\n",
       " 'Arachidonic acid metabolism': ['EPHX2'],\n",
       " 'Diflunisal Action Pathway': ['EPHX2'],\n",
       " 'Acetaminophen Action Pathway': ['EPHX2'],\n",
       " 'Phenylbutazone Action Pathway': ['EPHX2'],\n",
       " 'Salicylic Acid Action Pathway': ['EPHX2'],\n",
       " 'Salsalate Action Pathway': ['EPHX2'],\n",
       " 'Lornoxicam Action Pathway': ['EPHX2'],\n",
       " 'Flurbiprofen Action Pathway': ['EPHX2'],\n",
       " 'Lumiracoxib Action Pathway': ['EPHX2'],\n",
       " 'Fenoprofen Action Pathway': ['EPHX2'],\n",
       " 'Etoricoxib Action Pathway': ['EPHX2'],\n",
       " 'Tiaprofenic Acid Action Pathway': ['EPHX2'],\n",
       " 'Nepafenac Action Pathway': ['EPHX2'],\n",
       " 'Tenoxicam Action Pathway': ['EPHX2'],\n",
       " 'Magnesium Salicylate Action Pathway': ['EPHX2'],\n",
       " 'Salicylate-Sodium Action Pathway': ['EPHX2'],\n",
       " 'Antipyrine Action Pathway': ['EPHX2'],\n",
       " 'Antrafenine Action Pathway': ['EPHX2'],\n",
       " 'Leukotriene C4 Synthesis Deficiency': ['EPHX2'],\n",
       " 'Naproxen Action Pathway': ['EPHX2'],\n",
       " 'Oxaprozin Action Pathway': ['EPHX2'],\n",
       " 'Diclofenac Action Pathway': ['EPHX2'],\n",
       " 'Mefenamic Acid Action Pathway': ['EPHX2'],\n",
       " 'Ketoprofen Action Pathway': ['EPHX2'],\n",
       " 'Rofecoxib Action Pathway': ['EPHX2'],\n",
       " 'Bromfenac Action Pathway': ['EPHX2'],\n",
       " 'Arachidonic Acid Metabolism': ['EPHX2'],\n",
       " 'Sulindac Action Pathway': ['EPHX2'],\n",
       " 'Acetylsalicylic Acid Action Pathway': ['EPHX2'],\n",
       " 'Indomethacin Action Pathway': ['EPHX2'],\n",
       " 'Suprofen Action Pathway': ['EPHX2'],\n",
       " 'Etodolac Action Pathway': ['EPHX2'],\n",
       " 'Meloxicam Action Pathway': ['EPHX2'],\n",
       " 'Nabumetone Action Pathway': ['EPHX2'],\n",
       " 'Celecoxib Action Pathway': ['EPHX2'],\n",
       " 'Valdecoxib Action Pathway': ['EPHX2'],\n",
       " 'Piroxicam Action Pathway': ['EPHX2'],\n",
       " 'Trisalicylate-Choline Action Pathway': ['EPHX2'],\n",
       " 'Ibuprofen Action Pathway': ['EPHX2'],\n",
       " 'Tolmetin Action Pathway': ['EPHX2'],\n",
       " 'Ketorolac Action Pathway': ['EPHX2'],\n",
       " 'Carprofen Action Pathway': ['EPHX2'],\n",
       " 'IGF1 pathway': ['IGF1'],\n",
       " 'IGF1 signaling pathway ( IGF1 signaling pathway )': ['IGF1'],\n",
       " 'Stabilization and expansion of the E-cadherin adherens junction': ['IGF1'],\n",
       " 'Developmental Biology': ['IGF1'],\n",
       " 'TGF_beta_Receptor': ['ITGB3'],\n",
       " 'Arf6 signaling events': ['ITGB3'],\n",
       " 'Nectin adhesion pathway': ['ITGB3'],\n",
       " 'Integrin family cell surface interactions': ['ITGB3'],\n",
       " 'Osteopontin-mediated events': ['ITGB3']}"
      ]
     },
     "execution_count": 5,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pathways_to_genes = defaultdict(list)\n",
    "for gene, pathways in d.items():\n",
    "    for pathway in pathways:\n",
    "        pathways_to_genes[pathway].append(gene)\n",
    "path_to_genes = dict(pathways_to_genes)\n",
    "path_to_genes"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Now we need to get all the pairs which share pathways and all the pairs that do not - which are the two groups, A and B, that you mentioned a few days ago"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "170\n",
      "2458\n"
     ]
    }
   ],
   "source": [
    "A = []\n",
    "B = []\n",
    "key_pairs = combinations(d.keys(), 2)\n",
    "for key_pair in key_pairs:\n",
    "    key1, key2 = key_pair\n",
    "    if bool(set(d[key1]) & set(d[key2])):\n",
    "        A.append((key1, key2))\n",
    "    else:\n",
    "        B.append((key1, key2))\n",
    "print(len(A))\n",
    "print(len(B))"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "base",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.11.8"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
